Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

S100A8 and S100A9 Overexpression Is Associated with Poor Pathological Parameters in Invasive Ductal Carcinoma of the Breast open access plus

Volume:8   Issue:4
Pp: 243-252
Kazumori Arai, Sachiko Takano, Takumi Teratani, Yasuhiro Ito, Toshihiro Yamada and Ryushi Nozawa
DOI: 10.2174/156800908784533445

Cancer Neovascularization and Proinflammatory Microenvironments

Volume:8   Issue:4
Pp: 253-265
Mitsuko Furuya and Yoshikazu Yonemitsu
DOI: 10.2174/156800908784533481

Targeting Cancer and Neuropathy with Histone Deacetylase Inhibitors:Two Birds with One Stone?

Volume:8   Issue:4
Pp: 266-274
V. Rodriguez-Menendez, L. Tremolizzo and G. Cavaletti
DOI: 10.2174/156800908784533508

The Inhibitor of Growth (ING) Gene Family: Potential Role in Cancer Therapy

Volume:8   Issue:4
Pp: 275-284
Mehmet Gunduz, Esra Gunduz, Rosario S. Rivera and Hitoshi Nagatsuka
DOI: 10.2174/156800908784533454

Skeletal Muscle in Cancer Cachexia: The Ideal Target of Drug Therapy

Volume:8   Issue:4
Pp: 285-298
Maurizio Bossola, Fabio Pacelli, Antonio Tortorelli, Fausto Rosa and Giovan Battista Doglietto
DOI: 10.2174/156800908784533463

Regulators of Chemokine Receptor Activity as Promising Anticancer Therapeutics

Volume:8   Issue:4
Pp: 299-340
Konstantin V. Balakin, Yan A. Ivanenkov, Sergey E. Tkachenko, Alex S. Kiselyov and Alexandre V. Ivachtchenko
DOI: 10.2174/156800908784533490

Erratum promotion: free to download

Volume:8   Issue:4
Pp: 341-341

DOI: 10.2174/156800908784533472